Filing Details

Accession Number:
0001209191-22-043543
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-29 16:57:25
Reporting Period:
2022-07-28
Accepted Time:
2022-07-29 16:57:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1812364 Relay Therapeutics Inc. RLAY Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1899340 Andy Porter C/O Relay Therapeutics, Inc.
399 Binney St., 2Nd Floor
Cambridge MA 02139
Chief Administrative Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-07-28 452 $21.27 45,871 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 1,511 shares of restricted stock units ("RSUs") on July 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
  2. Includes 30,774 shares underlying RSUs.